Establishment of Patient-Derived Organoids for Pediatric Cancer Research
Cancers · 02.05.2026 · 18 (9) · 1465
DOI: 10.3390/cancers18091465 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 02.05.2026. Verfasst von Muhammad Younis und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Hematology/Oncology, College of Medicine, Pennsylvania State University, Hershey, PA 17033, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Four Diamonds, Beat Childhood Cancer Foundation.
Abstract (Originalsprache)
Background/Objectives: Pediatric cancers are disorders of dysregulated development driven largely by genomic and epigenetic alterations. Precisely modeling these developmental differences is essential for understanding the unique biology of childhood cancers. Patient-derived organoids (PDOs) offer a powerful in vitro platform that recapitulates tumor heterogeneity, plasticity, microenvironment (including immune cells) and disease-relevant features.
Methods
Here, we describe a step-by-step protocol for the establishment of PDOs from cells derived from pediatric brain tumors and extracranial solid tumor biopsies and bone marrow aspirates, including tumor processing, organoid culture/subculture, and cryopreservation.
Results
Furthermore, we present the use of PDOs for further experimental analysis such as fluorescence imaging, Western blotting, flow cytometry, and immunohistochemistry (IHC) to investigate the underlying pathophysiology of tumorigenesis.
Conclusions
Expanding the application of organoids to childhood malignancies holds exceptional promise for elucidating pediatric tumor biology and advancing therapeutic strategies, representing the long-overdue convergence of technology and clinical need.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Hematology/Oncology, College of Medicine, Pennsylvania State University, Hershey, PA 17033, USA.
- Pediatric Hematology and Oncology Division, Pennsylvania State University, Golisano Children's Hospital, Hershey, PA 17033, USA.
ORCID-Profile: Thussenthan Walter-Angelo, Franklin Back, Chandrika Behura, Vladimir S Spiegelman, Hong-Gang Wang, Jeremy Hengst
Förderung
- Four Diamonds
- Beat Childhood Cancer Foundation
Zitieren
APA
Younis, M., Arjmandi, T., Haque, M., McClain, K., Walter-Angelo, T., Back, F., Gandra, D., Moore, A., Behura, C., Spiegelman, V. S., Wang, H. G., Dovat, S., Hengst, J., & Sholler, G. S. (2026). Establishment of Patient-Derived Organoids for Pediatric Cancer Research. Cancers, 18(9), 1465. https://doi.org/10.3390/cancers18091465
Vancouver
Younis M, Arjmandi T, Haque M, McClain K, Walter-Angelo T, Back F, et al. Establishment of Patient-Derived Organoids for Pediatric Cancer Research. Cancers. 2026;18(9):1465. doi:10.3390/cancers18091465
BibTeX
@article{Younis2026,
author = {Younis, Muhammad and Arjmandi, Tarlan and Haque, Mohammad and McClain, Katherine and Walter-Angelo, Thussenthan and Back, Franklin and Gandra, Divya and Moore, Abigail and Behura, Chandrika and Spiegelman, Vladimir S and Wang, Hong-Gang and Dovat, Sinisa and Hengst, Jeremy and Sholler, Giselle Saulnier},
title = {Establishment of Patient-Derived Organoids for Pediatric Cancer Research},
journal = {Cancers},
year = {2026},
volume = {18},
number = {9},
pages = {1465},
doi = {10.3390/cancers18091465}
}
EUVIMED